Suit filed against OppenheimerFunds

JAN 09, 2009
OppenheimerFunds Inc. is facing what may be the first of many arbitration claims over losses in its Champion Income Fund. A claim filed Wednesday against Oppenheimer Investor Services Inc. of New York claims that two elderly investors, Ruth and Melvin Bruder of Lauderhill, Fla., lost $125,000 in the fund. Andrew Stoltmann, a plaintiff's attorney at The Stoltmann Law Offices PC in Chicago, who filed the case on behalf of Daniel Bruder, a trustee for his parents, said the case is the first one filed against Oppenheimer for losses stemming from a collapse in the price of the high-yielding bond fund. The suit claims the fund, which lost about 55% in November alone, was misrepresented to investors. It says the former portfolio manager, Angelo Manioudakis, who is also named in the suit, concentrated the fund in illiquid mortgage securities and credit default swaps. Mr. Stoltmann said he plans to file about 20 more cases against Oppenheimer. Jeaneen Pisarra, a spokeswoman for OppenheimerFunds, declined to comment.

Latest News

Retirement plan defaults leave key participant decisions unresolved
Retirement plan defaults leave key participant decisions unresolved

New Allspring research finds 401(k) participants want guidance on income and rollovers, not just portfolio automation.

Global equity release market set to triple, with US leading growth
Global equity release market set to triple, with US leading growth

Aging homeowners hold record housing wealth - but most advisors still aren't bringing it into retirement plans

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor